Efficacy and safety of rituximab for membranous nephropathy in adults: a meta-analysis of RCT
Rituximab demonstrates potential efficacy in treating MGN, with promising long-term outcomes and a favorable adverse event profile.
Authors
- Jia Wang (ORCID: https://orcid.org/0009-0003-7040-676X)
- Jiahui Han (ORCID: https://orcid.org/0000-0002-3999-751X)
- Bing Mao
- Kan Ye
Institutions
- Cixian People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.3389/fneph.2025.1548679
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 4.29